1213455-73-2 Usage
Uses
Used in Organic Synthesis:
(R)-2-(o-ethylphenyl)pyrrolidine is utilized as an intermediate in organic synthesis for the creation of various complex molecules and pharmaceutical compounds. Its unique structure and reactivity make it a valuable building block in the development of novel chemical entities.
Used in Pharmaceutical Research:
In the pharmaceutical industry, (R)-2-(o-ethylphenyl)pyrrolidine is employed as a key component in the research and development of new drugs. Its potential pharmacological properties are being explored for the treatment of various medical conditions, making it a promising candidate for future therapeutic applications.
Used in Chiral Compounds:
Due to its chiral center, (R)-2-(o-ethylphenyl)pyrrolidine is also used in the study and development of chiral compounds. Chirality plays a crucial role in the efficacy and safety of pharmaceuticals, and (R)-2-(o-ethylphenyl)pyrrolidine contributes to the understanding and application of chiral chemistry in drug design.
Check Digit Verification of cas no
The CAS Registry Mumber 1213455-73-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,3,4,5 and 5 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1213455-73:
(9*1)+(8*2)+(7*1)+(6*3)+(5*4)+(4*5)+(3*5)+(2*7)+(1*3)=122
122 % 10 = 2
So 1213455-73-2 is a valid CAS Registry Number.
1213455-73-2Relevant academic research and scientific papers
W?glarz, Izabela,Michalak, Karol,Mlynarski, Jacek
, p. 1317 - 1321 (2021)
The first successful enantioselective hydrosilylation of cyclic imines promoted by a chiral zinc complex is reported. In situ generated zinc-ProPhenol complex with silane afforded pharmaceutically relevant enantioenriched 2-aryl-substituted pyrrolidines in high yields and with excellent enantioselectivities (up to 99% ee). The synthetic utility of presented methodology is demonstrated in an efficient synthesis of the corresponding chiral cyclic amines, being pharmaceutical drug precursors to the Aticaprant and Larotrectinib. (Figure presented.).
